Clinical Trials
7 trialsNCT05582499 2026-05-28
FASCINATE-N
Fudan University
Phase 2 Recruiting
NCT05092373 2026-01-14
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT07057427 2025-07-09
Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Henan Cancer Hospital
Phase 3 Recruiting
NCT06143553 2024-11-29
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer
Shanghai Yizhong Pharmaceutical Co., Ltd.
Phase 3 Recruiting
NCT05205200 2024-02-08
Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
Fudan University
Phase 2 Recruiting
NCT05420454 2022-07-01
A Study for the Neoadjuvant Treatment of Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Recruiting
NCT05420467 2022-07-01
A Study for the Adjuvant Treatment of Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4 Recruiting